B cells can also be present in the TME, and among them, regulatory B cells are known for the release of immunoregulatory cytokines that hinder anti-tumor responses by inhibiting natural killer (NK) cells and CD8+ cytotoxic T cells [14]. The gene discussed is CD8A; the disease is neoplasm.